de Jong J L, Farner N L, Widmer M B, Giri J G, Sondel P M
Department of Human Oncology, University of Wisconsin, Madison 53792, USA.
J Immunol. 1996 Feb 15;156(4):1339-48.
This study was designed to compare the interactions of IL-2 and IL-15 with the IL-2R beta and IL-2R gamma c subunits, as differences in receptor interactions between IL-2 and IL-15 might contribute to the functional differences between these two cytokines. The results suggest the existence of a human IL-15R alpha subunit, although physical evidence of this molecule was not obtained. Proliferation of anti-CD3 (OKT3)-stimulated human PBL was compared for responsiveness to IL-2, IL-15, and F42K, and IL-2 mutant that does not bind the IL-2R alpha chain. F42K was more potent than IL-15 in activating a dose-dependent response. This fact, along with Scatchard binding analyses of IL-15 on OKT3 blasts and YT cells revealing both high and intermediate affinity receptors, supports the existence of IL-15R alpha on these cells. Additional characterization of the IL-15R utilized covalent cross-linking to affinity label IL-2R and IL-15R on YT cells and OKT3 blasts. Consistent with previously reported functional data, IL-2R alpha was not co-precipitated from the [125I]IL-15 receptor-ligand complex, demonstrating that IL-15 does not interact physically with the IL-2R alpha subunit. While IL-2R alpha did co-precipitate with IL-2R beta and IL-2R gamma c in the presence of IL-2, IL-15R alpha did not co-precipitate with the IL-2R beta/gamma c complex. Finally, YT cells equilibrated with IL-2 and then precipitated through IL-2R beta showed that IL-2R beta and IL-2R gamma c co-precipitate in a 1:1 ratio, while only IL-2R beta was found in the immunoprecipitates of YT cells equilibrated with IL-15. This indicates that IL-15 creates a less stable bridge between the IL-2R beta and IL-2R gamma c chains than does IL-2 on YT cells. This result was identical for both surface-iodinated YT cells and immunoprecipitates that were probed for IL-2R beta and IL-2R gamma c on Western blots.
本研究旨在比较白细胞介素-2(IL-2)和白细胞介素-15(IL-15)与IL-2Rβ和IL-2Rγc亚基的相互作用,因为IL-2和IL-15之间受体相互作用的差异可能导致这两种细胞因子功能上的差异。结果提示存在人IL-15Rα亚基,尽管未获得该分子的实体证据。比较了抗CD3(OKT3)刺激的人外周血淋巴细胞(PBL)对IL-2、IL-15和F42K(一种不结合IL-2Rα链的IL-2突变体)的增殖反应性。F42K在激活剂量依赖性反应方面比IL-15更有效。这一事实,连同对OKT3母细胞和YT细胞上IL-15的Scatchard结合分析显示出高亲和力和中等亲和力受体,支持了这些细胞上存在IL-15Rα。对IL-15R的进一步表征利用共价交联对YT细胞和OKT3母细胞上的IL-2R和IL-15R进行亲和标记。与先前报道的功能数据一致,在[125I]IL-15受体-配体复合物中未共沉淀出IL-2Rα,表明IL-15在实体上不与IL-2Rα亚基相互作用。虽然在IL-2存在的情况下IL-2Rα确实与IL-2Rβ和IL-2Rγc共沉淀,但IL-15Rα不与IL-2Rβ/γc复合物共沉淀。最后,用IL-2平衡然后通过IL-2Rβ沉淀的YT细胞显示,IL-2Rβ和IL-2Rγc以1:1的比例共沉淀,而在用IL-15平衡的YT细胞的免疫沉淀物中仅发现IL-2Rβ。这表明在YT细胞上,IL-15在IL-2Rβ和IL-2Rγc链之间形成的桥比IL-2形成的桥稳定性更低。对于表面碘化的YT细胞和在蛋白质印迹上检测IL-2Rβ和IL-2Rγc的免疫沉淀物,结果都是相同的。